Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

Li, JQ; Chen, YJ; Hu, F; Qiang, HP; Chang, Q; Qian, JL; Shen, YC; Cai, Y; Chu, TQ

Chu, TQ (通讯作者)，Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Resp Med, Shanghai, Peoples R China.;Cai, Y (通讯作者)，Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai, Peoples R China.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

BackgroundIn the first-line treatment of advanced non-small cell lung cancer (NSCLC), for those patients with negative PD-L1 expression, which treatme......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索